0 NASDAQ Companies - May 30, 2024Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing RequirementsNEW YORK, May 30, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (NASDAQ-GM: CAUD) has received an additional notification from the […]Read More
0 NYSE Companies - May 30, 2024Kimco Realty® Management to Present at Nareit’s REITweek: 2024 Investor ConferenceJERICHO, N.Y., May 30, 2024 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM) announced today that members of its management team […]Read More
0 NYSE Companies - May 30, 2024GameStop Announces Release Date for First Quarter Fiscal 2024 ResultsGRAPEVINE, Texas, May 30, 2024 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it […]Read More
0 NYSE Companies - May 30, 2024Ibotta Reports First Quarter 2024 Financial ResultsGrew revenue by 43% year-over-year to $82.3 million and non-GAAP revenue by 46% Delivered net income of $9.3 million, representing […]Read More
0 NASDAQ Companies - May 30, 2024Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare ConferenceFREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today […]Read More
0 NASDAQ Companies - May 30, 2024BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesWestport, CT, May 30, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology […]Read More
0 NASDAQ Companies - May 30, 2024Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]Read More
0 NASDAQ Companies - May 30, 2024NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease control […]Read More
0 NASDAQ Companies - May 30, 2024Aura Biosciences to Participate in the Jefferies Global Healthcare ConferenceBOSTON, May 30, 2024 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat […]Read More
0 NASDAQ Companies - May 30, 2024Ambarella, Inc. Announces First Quarter Fiscal Year 2025 Financial ResultsSANTA CLARA, Calif., May 30, 2024 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced […]Read More